Opportunities Abound: How Scientist.com Helps Providers of Market Access Services Grow Their Business
Market access services are essential in today's drug development landscape. Learn how partnering with Scientist.com can help providers grow their business by offering streamlined procurement, targeted visibility, and access to a global biotech audience.
Enhancing Clinical Trial Diversity: Insights on Action Plans and Regulatory Alignment
In a recent interview, Rachael Fones, director of government and public affairs at IQVIA, emphasized the importance of diversity action plans in clinical trials.
Bridge Biotherapeutics to Present Key Developments at JPM 2025
Bridge Biotherapeutics, a clinical-stage biotech company focusing on therapeutic areas with high unmet needs, has officially been slated to present at the 43rd annual J.P. Morgan Healthcare Conference.
Ionis Pharmaceuticals Achieves Milestone with FDA Approval of Treatment for Familial Chylomicronemia Syndrome (FCS)
Ionis Pharmaceuticals marks a new commercial era with the FDA approval of Tryngolza, a novel RNA-targeted treatment for familial chylomicronemia syndrome, embarking on its first solo drug launch to address unmet medical needs.
Bipartisan Bill Introduces Key Healthcare Reforms to Enhance Transparency and Access
On December 18, 2024, U.S. lawmakers unveiled a bipartisan stopgap funding bill to finance the federal government through March, incorporating significant healthcare provisions.
U.S. Government Accountability Office Links Rising Health Insurance Costs to Market Concentration and Fewer Insurer Choices
The U.S. Government Accountability Office (GAO) warned in early December of likely increases to health insurance costs in 2025 and highlighted increasing market concentration as a key factor, as three or fewer companies dominate 80% of enrollment in many states.
Merck’s Winrevair Shows Promise in Expanding Cardiovascular Treatment Market
Merck's cardiovascular drug Winrevair demonstrates significant efficacy in treating pulmonary arterial hypertension, potentially expanding its market presence as Keytruda faces patent expiration. Recent ZENITH trial results indicate promising outcomes for patients with severe lung hypertension.
Uncertain Future for Continuous Medicaid Eligibility for Children Under Potential Policy Changes
The Biden administration's approval of multiyear continuous Medicaid eligibility for children in five states faces uncertainty with the incoming Trump administration. Explore the implications of potential policy changes impacting Medicaid and CHIP enrollment.
UPDATE: Eli Lilly Joins J&J in Challenging Federal 340B Drug Discount Program in Court
Eli Lilly and Johnson & Johnson have filed lawsuits against the U.S. government over the administration of the 340B drug discount program, seeking to implement rebate systems for hospitals instead of providing upfront drug discounts. The legal actions highlight ongoing tensions between pharmaceutical companies and healthcare providers over program costs and compliance.
Market Access “Back to School”: How to Plan and Prioritize Your 2025 Projects
Plan for 2025 in biopharma with insights on adapting to market changes, leveraging digital tools, and engaging key opinion leaders. Ensure guideline inclusion and stay competitive with strategic positioning. Use this checklist to prioritize initiatives for the evolving landscape.
Johnson & Johnson Challenges Federal Government Over 340B Rebate Plan
Johnson & Johnson has filed a lawsuit against the Biden administration, seeking to implement a rebate model for the 340B drug discount program. The pharmaceutical giant aims to replace upfront discounts with after-the-fact rebates, a move met with opposition from hospitals and federal regulators.
APhA Supports ECAPS Act to Preserve Essential Pharmacy Access in Underserved Communities
In the wake of increased pharmacy closures, the American Pharmacists Association (APhA) has expressed support for [...]
Battling the Superbug Crisis: Urgent Need for Innovative Solutions and Increased Funding
The escalating threat of antimicrobial resistance (AMR) is outpacing current efforts to develop effective treatments, leading [...]
Unlocking Success: The Crucial Role of Market Access and HEOR in Biotech and Pharma Innovation
Industry experts discuss the importance of integrating market access and health economics early in drug development to enhance commercial success in the biotech and pharmaceutical sectors.
Study Finds Access to Public Health Insurance Boosts Cognitive Development in Children
A recent study published in the Journal of Health Economics reveals that expanding public health insurance [...]
Enovo Life Sciences Launches Biologics and Advanced Therapies Platform with Warburg Pincus
Enovo Life Sciences, co-founded by life sciences veterans Mario Philips and Roel Gordijn, has launched in [...]
FDA Announces Eli Lilly’s Mounjaro and Zepbound Are No Longer in Shortage
The U.S. Food and Drug Administration (FDA) announced that Eli Lilly’s weight-loss drug tirzepatide, marketed as [...]
Albert Einstein College Secures $14M Annual Grant for Pandemic Preparedness Research
The Albert Einstein College of Medicine has received a substantial five-year grant of $14M per year [...]
Biotech IPO Boom: $700M Raised as Market Eyes 2025 Recovery
Three biotech startups—Bicara Therapeutics, Zenas BioPharma, and MBX Biosciences—raised over $700 million in IPOs, marking a [...]
Future Growth and Challenges in the Migraine Drug Market
The migraine market in the US, France, Germany, Italy, Spain, UK, and Japan is expected to [...]
Biocon Biologics Secures Global Commercialization Path for Stelara® Biosimilar
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has reached a settlement and license agreement [...]
ePharmacy Market Set for Major Growth with North America and Asia-Pacific Leading the Way
The global ePharmacy market is valued at USD 82.6 billion in 2023, and is projected to [...]
Dr. Reddy’s Laboratories Shares Surge on Potential Anti-Malarial Drug Partnership
Dr. Reddy's Laboratories shares hit an all-time high of Rs 7,101 per share on the BSE, [...]
Tirzepatide Shows Promise in Preventing Type 2 Diabetes and Sustaining Weight Loss
Eli Lilly’s tirzepatide -- a proven success in treating type 2 diabetes and obesity -- has [...]
Antibody Drug Conjugates: Leading Innovation in Cancer Treatment and Pharmaceutical Deals
Since 2023, antibody-drug conjugates have been at the forefront of high-value pharmaceutical deals, with major companies [...]
